four of these were also bled on a third occasion. The figure shows the serial results for those patients positive in any one of the IgG anticardiolipin antibody or coagulation tests. Nine patients who were IgG anticardiolipin antibody positive on the first occasion all remained positive (figure A). Only one of the other 14 patients (patient A) became IgG anticardiolipin antibody positive and this at low levels. The relation between disease activity, pregnancy, and treatment and anticardiolipin antibody concentrations in a larger number of patients over a longer period is the subject of a separate study.
Nine of the 23 patients studied serially had an abnormal KCCT on at least one occasion (figure B), six of these nine had at least one abnormal TTIT (figure C), and six of these nine had at least one abnormal RWT (figure D). Most patients who were lupus anticoagulant positive by one assay in the initial sample remained positive by that respective assay in the second or third samples. Conversely, 14 of the 23 patients studied serially were lupus anticoagulant negative in all three assays on first sampling and remained so on serial samples.
Although there were occasional discordant fluctuations between the IgG anticardiolipin antibody concentrations and the coagulation times most often any variation was in the same direction. IgG anticardiolipin antibody concentrations returned to normal in only one patient (patient D, figure A), and this patient had no evidence of a lupus anticoagulant. An initially raised KCCT in three patients became normal. In one patient (patient I, figure B) Three patients were lupus anticoagulant positive on at least one occasion (by all three assays) and were consistently anticardiolipin antibody negative (including patients M and L, figures B, C, and D). One of these patients had a previous deep vein thrombosis (patient M), one had severe mitral valve regurgitation which had required replacement and florid livedo reticularis, though had experienced no thromboembolic episodes (patient L), and the third had no unusual features. A fourth patient who had an abnormal RWT alone (28 seconds) had an illness characterised by non-erosive arthritis and haemolytic anaemia. A fifth patient (patient N, figure B) had an abnormal KCCT alone on two occasions during an uneventful twin pregnancy while she was receiving no drugs.
OTHER CLINICAL FEATURES
In this study we were unable to find a significant association between the presence of livedo reticularis and either anticardiolipin antibodies or lupus anticoagulant. This may be because a smaller number were studied than in our earlier report6 and because the few patients who were receiving anticoagulants were excluded.
Only one patient in this study had recurrent pregnancy loss (patient F), an uncommon feature in our group with systemic lupus erythematosus.2' This patient also had a cerebrovascular accident, livedo reticularis, and was both anticardiolipin antibody and lupus anticoagulant positive.
Discussion
The lupus anticoagulant is an acquired inhibitor of coagulation, which has immunological reactivity towards anionic phospholipid.22 It is likely that lupus anticoagulants prolong phospholipid dependent coagulation by acting at the junction of the intrinsic and extrinsic coagulation pathways, interacting with the phospholipid portion of the prothrombinase complex, without inhibiting the activity of specific coagulation factors. This is shown by the fact that the inhibition of in vitro coagulation is immediate and does not increase progressively with incubation time."3 In vivo the lupus anticoagulant is associated with thrombosis and thrombocytopenia rather than haemorrhage, probably owing to the extra presence of platelet and endothelial surfaces, but the exact mechanism is uncertain.
The introduction of solid phase assays for measuring antiphospholipid antibodies has allowed more rapid screening of patient groups at risk of harbouring a lupus anticoagulant, and an abundance of reports confirming the aforeseen associations (reviewed in ref 9 26 27 It was not the intention of this study to find the most optimal assay for either of these purposes. We chose three representative assays that could be most conveniently performed in our routine haematology tests and that between them could detect abnormalities in intrinsic (KCCT) and extrinsic (TTIT) clotting pathways. The RVVT, which is independent of both systems, is less affected by the presence of antibodies to factor VIII, IX, or XI,'5 which have been reported to cause false positive results in the TTIT assay.27 In our hands the KCCT was the most sensitive assay and the TTIT was the most specific assay in identifying a group of patients with either thrombosis or thrombocytopenia. It is unlikely that antibodies to specific factors have influenced the results as the coagulation times did not increase during prolonged incubation and there was a high correlation between all assays used. We have not assessed more recently reported platelet neutralisation methods, which may be more specific for detecting a lupus anticoagulant.27 Until better standardisation is achieved it seems sensible for individual laboratories to use at least two assays for measuring lupus anticoagulant activity which are felt reliable under local conditions. In summary, determination of IgG anticardiolipin antibodies by an ELISA is a good but less than perfect screening assay for the presence of a lupus anticoagulant as there are occasional patients with the anticoagulant alone. The presence of a lupus anticoagulant in anticardiohlpin antibody positive patients is important as an indicator of increased specificity for antiphospholipid related events. 
